Amelioration of experimental autoimmune encephalomyelitis by in vivo reprogramming of macrophages using pro-resolving factors

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Amelioration of experimental autoimmune encephalomyelitis by in vivo reprogramming of macrophages using pro-resolving factors ; volume:20 ; number:1 ; day:20 ; month:12 ; year:2023 ; pages:1-19 ; date:12.2023
Journal of neuroinflammation ; 20, Heft 1 (20.12.2023), 1-19, 12.2023

Creator
Gauthier, Thierry
Martin-Rodriguez, Omayra
Chagué, Cécile
Daoui, Anna
Ceroi, Adam
Varin, Alexis
Bonnefoy, Francis
Valmary-Degano, Séverine
Couturier, Mélanie
Behlke, Susanne
Saas, Philippe
Cartron, Pierre-François
Perruche, Sylvain
Contributor
SpringerLink (Online service)

DOI
10.1186/s12974-023-02994-5
URN
urn:nbn:de:101:1-2024030609212786226227
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Gauthier, Thierry
  • Martin-Rodriguez, Omayra
  • Chagué, Cécile
  • Daoui, Anna
  • Ceroi, Adam
  • Varin, Alexis
  • Bonnefoy, Francis
  • Valmary-Degano, Séverine
  • Couturier, Mélanie
  • Behlke, Susanne
  • Saas, Philippe
  • Cartron, Pierre-François
  • Perruche, Sylvain
  • SpringerLink (Online service)

Other Objects (12)

Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses

Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor

Neonatal tolerance and experimental autoimmune encephalomyelitis

Hochschulschrift

Neonatal tolerance and experimental autoimmune encephalomyelitis

Neuronal Response to Experimental Autoimmune Encephalomyelitis

Neuronal Response to Experimental Autoimmune Encephalomyelitis

Autoimmune T cell - B cell interaction in experimental autoimmune encephalomyelitis

Hochschulschrift

Autoimmune T cell - B cell interaction in experimental autoimmune encephalomyelitis

Role of eosinophils in experimental autoimmune encephalomyelitis

Role of eosinophils in experimental autoimmune encephalomyelitis

Sapropterin (BH4) Aggravates Autoimmune Encephalomyelitis in Mice

Sapropterin (BH4) Aggravates Autoimmune Encephalomyelitis in Mice

Thymic Innervation Impairment in Experimental Autoimmune Encephalomyelitis

Thymic Innervation Impairment in Experimental Autoimmune Encephalomyelitis

Sapropterin (BH4) aggravates autoimmune encephalomyelitis in mice

Sapropterin (BH4) aggravates autoimmune encephalomyelitis in mice

Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses

Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis

ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis

ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis

Related objects